IMNM with anti-SRP antibody is characterized by severe muscle weakness, very high levels of creatine kinase (CK), relatively infrequent extra-muscular involvement including rashes and interstitial lung disease, and refractory to steroid treatment [1–3]. Here, UCN2 is linked to interstitial lung disease.